2 -oxo-I -pyrrolidine derivatives/ processes for preparing them and their therapeutic use on the central nervous system

Details for Australian Patent Application No. 2006254336 (hide)

Owner UCB Pharma S.A.

Inventors Turet, Laurent; Ates, Ali; Quesnel, Yannick; Mercier, Joel; Michel, Philippe; Kenda, Benoit

Agent Watermark

Pub. Number AU-B-2006254336

PCT Pub. Number WO2006/128693

Priority 05011780.3 01.06.05 EP; 05011779.5 01.06.05 EP

Filing date 31 May 2006

Wipo publication date 7 December 2006

Acceptance publication date 4 October 2012

International Classifications

C07D 401/06 Heterocyclic compounds containing two or more hetero rings

A61K 31/404

A61K 31/4155 - not condensed and containing further heterocyclic rings

A61K 31/4178

A61K 31/427 - not condensed and containing further heterocyclic rings

A61K 31/433 - Thiadiazoles

A61K 31/435 - having six-membered rings with one nitrogen as the only ring hetero atom

C07D 403/06 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 473/00 Heterocyclic compounds containing purine ring systems

Event Publications

3 January 2008 PCT application entered the National Phase

  PCT publication WO2006/128693 Priority application(s): WO2006/128693

4 October 2012 Application Accepted

  Published as AU-B-2006254336

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006254337-Safety device for motorized access passageways

2006254335-2-oxo-1-pyrrolidine derivatives and their therapeutic use on the central nervous system